GGenetics Read More Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal21 May 2025 Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for…